# BRIP1

## Overview
BRIP1, or BRCA1 Interacting Protein C-terminal Helicase 1, is a gene located on chromosome 17q22 that encodes for the protein BRCA1 interacting helicase 1. This protein is a member of the RecQ DEAH helicase family and plays a pivotal role in DNA repair processes, particularly in the homologous recombination and repair of DNA double-strand breaks. The interaction between BRIP1 and the tumor suppressor protein BRCA1 is crucial for maintaining genomic stability, a key factor in preventing carcinogenesis. The protein's helicase activity, which involves unwinding DNA in an ATP-dependent manner, is essential for the proper execution of DNA repair mechanisms and the maintenance of cellular integrity (De2008A; Ma2013BRIP1). BRIP1's function and its interactions with other proteins underscore its importance in the cellular response to DNA damage and its implications in cancer predisposition, particularly in ovarian and breast cancers (Moyer2020Rare; Milano2023Genetic).

## Function
BRIP1, or BRCA1 interacting protein C-terminal helicase 1, encodes a DNA helicase that plays a critical role in the DNA repair mechanisms of healthy human cells, particularly through its interaction with the BRCA1 protein. This interaction is crucial for the repair of DNA double-strand breaks and interstrand cross-link (ICL) damage, which are significant for maintaining genomic stability (Moyer2020Rare; De2008A). BRIP1 is involved in the homologous recombination-mediated repair of double-strand breaks, a process vital for the accurate repair of DNA damages (Ma2013BRIP1). 

The protein encoded by BRIP1 is an ATP-dependent 5'-3' DNA helicase, which unwinds DNA at specific structures like forked duplex substrates and D-loops, essential for the resolution of stalled replication forks (Moyer2020Rare). This activity is critical for the execution of the G2/M cell cycle checkpoint and normal progression through the S phase, highlighting its role in cell cycle regulation in response to DNA damage (Moyer2020Rare; Ma2013BRIP1).

Furthermore, BRIP1 contains several domains critical for its function, including an iron-sulfur (Fe-S) binding domain unique among DEAH helicase family members, which may contribute to its specific interactions and functions within the DNA repair pathways (Moyer2020Rare).

## Clinical Significance
Mutations in the BRIP1 gene are associated with several hereditary conditions and cancers, notably Fanconi anemia and ovarian cancer. Homozygous or compound heterozygous mutations in BRIP1 can lead to Fanconi anemia, a disorder characterized by congenital abnormalities, bone marrow failure, and increased cancer risk (Kamal2020Helicase-inactivating). Specifically, the p.R848H mutation in BRIP1, when homozygous, is linked to Fanconi anemia with features such as microcephaly and congenital abnormalities (Kamal2020Helicase-inactivating).

In the context of cancer, heterozygous loss-of-function mutations in BRIP1 predispose individuals to ovarian cancer, with guidelines suggesting risk-reducing measures for carriers (Kamal2020Helicase-inactivating). Although its role in breast cancer risk remains less clear, BRIP1 has been implicated in hereditary breast cancer, particularly in families not explained by BRCA1 and BRCA2 mutations (Milano2023Genetic). Additionally, recent studies have begun to explore the association between BRIP1 mutations and hereditary colorectal cancer, particularly in familial colorectal cancer Type X (MartÃ­n-Morales2021BRIP1).

Overall, the clinical significance of BRIP1 mutations underscores the importance of genetic testing and surveillance in individuals with a family history of these conditions, to manage and mitigate associated risks effectively.

## Interactions
BRIP1, also known as FANCJ or BACH1, is a DNA helicase that interacts with the BRCA1 protein through the BRCA1 C-terminal (BRCT) domains, playing a crucial role in DNA repair mechanisms. This interaction is essential for the repair of DNA double-strand breaks and for controlling DNA damage-induced checkpoints during the G2/M phase of the cell cycle (De2008A; Eelen2008Expression). BRIP1 also forms complexes with other proteins such as CLSPN, FANCI, DTL, BRCA1, and TMPO, which are involved in various biological pathways including homologous recombination and nucleotide excision repair (Wang2023Multimolecular).

In addition to its interaction with BRCA1, BRIP1 binds with high affinity to the RPA70 subunit of the RPA heterotrimer, enhancing its helicase activity, especially in the presence of thymine glycol on DNA. This interaction is significant in the context of DNA unwinding and repair (Suhasini2009FANCJ). Furthermore, BRIP1 interacts with proteins such as Wwox and CtIP, playing a role in the DNA damage response, independent of BRCA1 (Park2022Wwox).

These interactions highlight BRIP1's multifaceted role in maintaining genomic stability and its involvement in various DNA repair pathways, underscoring its importance in cellular biology and cancer predisposition.


## References


[1. (De2008A) Arcangela De Nicolo, Mariella Tancredi, Grazia Lombardi, Cristina Chantal Flemma, Serena Barbuti, Claudio Di Cristofano, Bijan Sobhian, Generoso Bevilacqua, Ronny Drapkin, and Maria Adelaide Caligo. A novel breast cancerâassociated brip1 (fancj/bach1) germ-line mutation impairs protein stability and function. Clinical Cancer Research, 14(14):4672â4680, July 2008. URL: http://dx.doi.org/10.1158/1078-0432.ccr-08-0087, doi:10.1158/1078-0432.ccr-08-0087. (84 citations) 10.1158/1078-0432.ccr-08-0087](https://doi.org/10.1158/1078-0432.ccr-08-0087)

[2. (Kamal2020Helicase-inactivating) Lara Kamal, Sarah B. Pierce, Christina Canavati, Amal Abu Rayyan, Tamara Jaraysa, Orit Lobel, Suhair Lolas, Barbara M. Norquist, Grace Rabie, Fouad Zahdeh, Ephrat Levy-Lahad, Mary-Claire King, and Moien N. Kanaan. Helicase-inactivating brip1 mutation yields fanconi anemia with microcephaly and other congenital abnormalities. Molecular Case Studies, 6(5):a005652, October 2020. URL: http://dx.doi.org/10.1101/mcs.a005652, doi:10.1101/mcs.a005652. (2 citations) 10.1101/mcs.a005652](https://doi.org/10.1101/mcs.a005652)

[3. (Ma2013BRIP1) X.D. Ma, G.Q. Cai, W. Zou, Y.H. Huang, J.R. Zhang, D.T. Wang, and B.L. Chen. Brip1 variations analysis reveals their relative importance as genetic susceptibility factor for cervical cancer. Biochemical and Biophysical Research Communications, 433(2):232â236, April 2013. URL: http://dx.doi.org/10.1016/j.bbrc.2013.02.089, doi:10.1016/j.bbrc.2013.02.089. (17 citations) 10.1016/j.bbrc.2013.02.089](https://doi.org/10.1016/j.bbrc.2013.02.089)

[4. (Eelen2008Expression) G Eelen, I Vanden Bempt, L Verlinden, M Drijkoningen, A Smeets, P Neven, M R Christiaens, K Marchal, R Bouillon, and A Verstuyf. Expression of the brca1-interacting protein brip1/bach1/fancj is driven by e2f and correlates with human breast cancer malignancy. Oncogene, 27(30):4233â4241, March 2008. URL: http://dx.doi.org/10.1038/onc.2008.51, doi:10.1038/onc.2008.51. (41 citations) 10.1038/onc.2008.51](https://doi.org/10.1038/onc.2008.51)

[5. (Park2022Wwox) Dongju Park, Mehdi Gharghabi, Colleen R. Reczek, Rebecca Plow, Charles Yungvirt, C. Marcelo Aldaz, and Kay Huebner. Wwox binding to the murine brca1-brct domain regulates timing of brip1 and ctip phospho-protein interactions with this domain at dna double-strand breaks, and repair pathway choice. International Journal of Molecular Sciences, 23(7):3729, March 2022. URL: http://dx.doi.org/10.3390/ijms23073729, doi:10.3390/ijms23073729. (2 citations) 10.3390/ijms23073729](https://doi.org/10.3390/ijms23073729)

[6. (Moyer2020Rare) Cassandra L. Moyer, Jennifer Ivanovich, Jessica L. Gillespie, Rachel Doberstein, Marc R. Radke, Marcy E. Richardson, Scott H. Kaufmann, Elizabeth M. Swisher, and Paul J. Goodfellow. Rare brip1 missense alleles confer risk for ovarian and breast cancer. Cancer Research, 80(4):857â867, February 2020. URL: http://dx.doi.org/10.1158/0008-5472.can-19-1991, doi:10.1158/0008-5472.can-19-1991. (47 citations) 10.1158/0008-5472.can-19-1991](https://doi.org/10.1158/0008-5472.can-19-1991)

[7. (Suhasini2009FANCJ) Avvaru N. Suhasini, Joshua A. Sommers, Aaron C. Mason, Oleg N. Voloshin, R. Daniel Camerini-Otero, Marc S. Wold, and Robert M. Brosh. Fancj helicase uniquely senses oxidative base damage in either strand of duplex dna and is stimulated by replication protein a to unwind the damaged dna substrate in a strand-specific manner. Journal of Biological Chemistry, 284(27):18458â18470, July 2009. URL: http://dx.doi.org/10.1074/jbc.m109.012229, doi:10.1074/jbc.m109.012229. (46 citations) 10.1074/jbc.m109.012229](https://doi.org/10.1074/jbc.m109.012229)

[8. (Wang2023Multimolecular) Ruohuang Wang, Jisheng Zhang, Xin Cui, Shun Wang, Ting Chen, Yanfang Niu, Xiaoyun Du, Jingwen Kong, Lin Wang, and Yan Jiang. Multimolecular characteristics and role of brca1 interacting protein c-terminal helicase 1 (brip1) in human tumors: a pan-cancer analysis. World Journal of Surgical Oncology, March 2023. URL: http://dx.doi.org/10.1186/s12957-022-02877-8, doi:10.1186/s12957-022-02877-8. (3 citations) 10.1186/s12957-022-02877-8](https://doi.org/10.1186/s12957-022-02877-8)

[9. (Milano2023Genetic) Genetic and molecular analyses of candidate germlineBRIP1/FANCJvariants implicated in breast and ovarian cancer (0 citations) 10.1101/2023.07.03.23290133](https://doi.org/10.1101/2023.07.03.23290133)

[10. (MartÃ­n-Morales2021BRIP1) Lorena MartÃ­n-Morales, Pilar Garre, VÃ­ctor Lorca, Marta Cazorla, Patricia Llovet, Inmaculada Bando, Vanesa GarcÃ­a-Barberan, MarÃ­a Luisa GonzÃ¡lez-Morales, Clara Esteban-Jurado, Miguel de la Hoya, Sergi CastellvÃ­-Bel, and Trinidad CaldÃ©s. Brip1, a gene potentially implicated in familial colorectal cancer type x. Cancer Prevention Research, 14(2):185â194, February 2021. URL: http://dx.doi.org/10.1158/1940-6207.capr-20-0316, doi:10.1158/1940-6207.capr-20-0316. (11 citations) 10.1158/1940-6207.capr-20-0316](https://doi.org/10.1158/1940-6207.capr-20-0316)